[1] |
ZHENG Ya-mei, XIE Tian, WU Zhuo-le, CHEN Yong-xing.
Clinical value of triple-drug adjuvant therapy for tuberculous pleurisy via chest wall ultrasound
[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 695-700.
|
[2] |
XIA Lu,LU Shui-hua,LIU Ping.
Research progress of immune regulatory mechanism of traditional Chinese medicine on tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(2): 168-172.
|
[3] |
LI Meng, LU Li-ping, JIANG Qi, HONG Jian-jun, GAO Qian, YANG Chong-guang, GUO Xiao-qin.
Analysis of the types and expense of therapeutic drugs for pulmonary tuberculosis in Songjiang District of Shanghai
[J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1329-1332.
|
[4] |
Jia-wen WANG,Shan-shan HUANG,Kai-yi LIU,Hong-di LIANG,Hui-ying FENG,Fang-jing ZHOU,An-qi LIANG,Liang CHEN,Lin ZHOU.
The effectiveness evaluation of using mobile communication for directly observed short course chemotherapy on tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2019, 41(9): 946-950.
|
[5] |
Fei-yong RAN,Lei FU,Bin WANG,Shao-chen GUO,Yu LU,Xiao-you CHEN.
Evaluation of the effect of vitamin D on adjuvant therapy in the Guinea Pig model of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2018, 40(5): 512-518.
|
[6] |
Lu Yu,Zhao Weijie,Zheng Meiqin,et al..
Effective treatment of tuberculosis in mice with nanoparticulated streptomycin
[J]. Chinese Journal of Antituberculosis, 2008, 30(6): 502-505.
|
[7] |
Wang Jing,Tu Dehua,Li Bo,et al..
The incidence of the adverse reactions of the first-line anti-tuberculosis drugs in Beijing and its influence on the chemotherapy
[J]. Chinese Journal of Antituberculosis, 2008, 30(4): 271-274.
|
[8] |
Jiang Li,Zhong Qiu,Huang Guiqing,et al..
The dynamic evaluation model for prediction the result of chemotherapy in new smear positive pulmonary tuberculosis cases
[J]. Chinese Journal of Antituberculosis, 2007, 29(2): 130-132.
|
[9] |
Li Xiangqun,Mei Jian,Xia Zhen..
Analysis on causes and outcomes of irregular treatment of 333 pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2006, 28(6): 379-381.
|
[10] |
Zhong Qiu1,Huang Guiqing,Zhang Ming,et al..
Study on using fixed-dose combinations in Provincial Tuberculosis Programe
[J]. Chinese Journal of Antituberculosis, 2006, 28(5): 274-277.
|
[11] |
Shen Xin,Mei Jian,Shen Mei,et al..
The effect of drug resistance on treatment of tuberculosis
[J]. Chinese Journal of Antituberculosis, 2006, 28(5): 309-312.
|
[12] |
Wang Sumin,Wang Xuejing,Zhao Xinping,et al..
Research on treatment efficacy of the patients with drug resistance in the project for drug resistance surveillance in Guangdong and Zhejiang provinces
[J]. Chinese Journal of Antituberculosis, 2005, 27(6): 370-373.
|
[13] |
Lu Yu,Gao Mengqiu,Chu Naihui,et al..
Measurement of messenger RNA in Mycobacterium tuberculosis from sputum as a marker for monitoring the response to chemotherapy
[J]. Chinese Journal of Antituberculosis, 2005, 27(5): 281-284.
|
[14] |
Yang Song,Zhang Yaoting,Yin Jiantuan..
Therapeutic effect of compound glycyrrhizin and reductive glutathione on the fourty-eight inpatients suffered from hepatitis resulted from anti-tuberculous drugs
[J]. Chinese Journal of Antituberculosis, 2005, 27(5): 327-329.
|
[15] |
Zhu Yaojin Xu Long..
The clinical observation on treatment effect of gatifloxacin for the gerontism tuberculosis affiliate lower respiratory infection cases
[J]. Chinese Journal of Antituberculosis, 2005, 27(5): 325-326.
|